DDOG.NASDAQDatadog, INC

Form 4: Datadog CEO Olivier Pomel Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Datadog's CEO, Olivier Pomel, exercised stock options and sold Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

  • On September 9, 2024, Olivier Pomel, the CEO of Datadog, Inc., executed a stock option to acquire 150,240 shares of Class B Common Stock for $0.3067 per share.
  • Pomel converted 150,240 shares of Class B Common Stock into Class A Common Stock.
  • He also sold 60,010 shares of Class A Common Stock at a weighted-average price of $107.5075, 24,688 shares at $108.1015, and 939 shares at $108.8841.
  • These sales were executed under a 10b5-1 plan established on March 15, 2023.
  • Following these transactions, Pomel directly owns 392,111 shares of Class A Common Stock and 8,876,343 derivative securities related to Class B Common Stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are part of a pre-arranged plan and do not necessarily indicate a change in the CEO's confidence in the company.

Positives

  • The execution of a pre-arranged 10b5-1 trading plan allows insiders to diversify their holdings while avoiding accusations of trading on inside information.

Risks

  • While the sales are under a 10b5-1 plan, large sales by insiders can sometimes be perceived negatively by the market.

Industry Context

Insider transactions are common, and the use of 10b5-1 plans is a standard practice for executives to manage their stock holdings while complying with regulations.

Comparison to Industry Standards

  • The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the technology sector like Datadog.
  • Companies such as Microsoft, Amazon, and Google also have executives who utilize similar plans to manage their stock sales.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the effect of stock sales on the market price.

Key Dates

DateDescription
March 15, 2023Date of the 10b5-1 plan
June 5, 2024Date of prior Form 4 filing with an error in share count
September 9, 2024Date of the transactions: option exercise, conversion, and stock sales
September 11, 2024Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.